Giulia Fontanelli

591 total citations
21 papers, 409 citations indexed

About

Giulia Fontanelli is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Giulia Fontanelli has authored 21 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 10 papers in Hematology and 4 papers in Molecular Biology. Recurrent topics in Giulia Fontanelli's work include Chronic Myeloid Leukemia Treatments (7 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Neonatal Respiratory Health Research (4 papers). Giulia Fontanelli is often cited by papers focused on Chronic Myeloid Leukemia Treatments (7 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Neonatal Respiratory Health Research (4 papers). Giulia Fontanelli collaborates with scholars based in Italy, United Kingdom and Canada. Giulia Fontanelli's co-authors include Carlo Dani, Simone Pratesi, Giovanna Bertini, Jacopo Barp, Chiara Poggi, Firmino F. Rubaltelli, Iuri Corsini, Claudia Baratè, Sara Galimberti and Elettra Berti and has published in prestigious journals such as Blood, PLoS ONE and British Journal of Haematology.

In The Last Decade

Giulia Fontanelli

21 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giulia Fontanelli Italy 10 165 99 94 92 80 21 409
R Heidler Germany 3 156 0.9× 76 0.8× 45 0.5× 42 0.5× 80 1.0× 8 715
Kres̆imir Gales̃ić Croatia 12 179 1.1× 20 0.2× 42 0.4× 47 0.5× 40 0.5× 61 474
V Deutsch Israel 11 85 0.5× 104 1.1× 27 0.3× 74 0.8× 14 0.2× 19 423
Jacob Marsvin Laurberg Denmark 5 123 0.7× 20 0.2× 22 0.2× 23 0.3× 34 0.4× 5 319
Y Pawlotsky France 11 52 0.3× 161 1.6× 116 1.2× 9 0.1× 35 0.4× 52 480
Raj Warrier United States 13 64 0.4× 108 1.1× 86 0.9× 25 0.3× 7 0.1× 46 386
Takashi Iwakiri Japan 14 130 0.8× 53 0.5× 28 0.3× 32 0.3× 29 0.4× 20 408
H P Krohn Germany 9 88 0.5× 58 0.6× 68 0.7× 24 0.3× 8 0.1× 16 420
G.B. Fogazzi Italy 9 129 0.8× 59 0.6× 23 0.2× 31 0.3× 22 0.3× 15 437
Andrew Saunders United Kingdom 10 38 0.2× 46 0.5× 38 0.4× 25 0.3× 9 0.1× 24 464

Countries citing papers authored by Giulia Fontanelli

Since Specialization
Citations

This map shows the geographic impact of Giulia Fontanelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Fontanelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Fontanelli more than expected).

Fields of papers citing papers by Giulia Fontanelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Fontanelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Fontanelli. The network helps show where Giulia Fontanelli may publish in the future.

Co-authorship network of co-authors of Giulia Fontanelli

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Fontanelli. A scholar is included among the top collaborators of Giulia Fontanelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Fontanelli. Giulia Fontanelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gozzetti, Alessandro, Elisabetta Antonioli, Enrico Orciuolo, et al.. (2021). Real-Life Experience with Pomalidomide plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma: A Retrospective and Prospective Study. Medicina. 57(9). 900–900. 4 indexed citations
2.
Bernardeschi, Paolo, et al.. (2019). Sudden ventricular fibrillation and death during ibrutinib therapy—A case report. European Journal Of Haematology. 103(4). 442–443. 5 indexed citations
3.
Galeotti, Laura, F. Ceccherini, Marco Laurino, et al.. (2017). Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia. Cancer Chemotherapy and Pharmacology. 79(4). 767–773. 7 indexed citations
4.
Bocchia, Monica, Sara Galimberti, Anna Sicuranza, et al.. (2016). Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients. Oncotarget. 7(44). 72311–72321. 21 indexed citations
5.
Galimberti, Sara, Giulia Fontanelli, Simone Barsotti, et al.. (2015). PDGFRB sustains the "Withdrawal Syndrome" after Imatinib discontinuation. CINECA IRIS Institutial research information system (University of Pisa). 100. 697–697. 2 indexed citations
6.
Fontanelli, Giulia, Claudia Baratè, Elena Ciabatti, et al.. (2015). Real‐Time PCR and Droplet Digital PCR: two techniques for detection of the JAK2V617F mutation in Philadelphia‐negative chronic myeloproliferative neoplasms. International Journal of Laboratory Hematology. 37(6). 766–773. 26 indexed citations
7.
Crea, Francesco, Antonello Di Paolo, Francesca Guerrini, et al.. (2015). Polycomb Genes are Associated with Response to Imatinib in Chronic Myeloid Leukemia. Epigenomics. 7(5). 757–765. 11 indexed citations
8.
Paolo, Antonello Di, Giulia Cervetti, Claudia Baratè, et al.. (2014). The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia. The Pharmacogenomics Journal. 14(4). 328–335. 36 indexed citations
9.
Fimognari, Carmela, Eleonora Turrini, Piero Sestili, et al.. (2014). Antileukemic Activity of Sulforaphane in Primary Blasts from Patients Affected by Myelo- and Lympho-Proliferative Disorders and in Hypoxic Conditions. PLoS ONE. 9(7). e101991–e101991. 17 indexed citations
10.
Galimberti, Sara, Laura Galeotti, F. Ceccherini, et al.. (2014). Transmembrane Transporters hOCT1 and SLCO1B3 Polymorphisms Could Have a Role in Patients Affected By Chronic Myeloid Leukemia Treated with Nilotinib. Blood. 124(21). 3608–3608. 1 indexed citations
11.
Fontanelli, Giulia, F Caracciolo, E. Benedetti, et al.. (2013). Sorafenib As Monotherapy or in Association With Cytarabine and Clofarabine for the Treatment of Relapsed/Refractory FLT3 ITD-Positive Advanced Acute Myeloid Leukemia. Clinical Lymphoma Myeloma & Leukemia. 14(1). e13–e17. 2 indexed citations
12.
Dani, Carlo, et al.. (2012). Heliox non-invasive ventilation for preventing extubation failure in preterm infants. The Journal of Maternal-Fetal & Neonatal Medicine. 26(6). 603–607. 9 indexed citations
13.
Poggi, Chiara, Giulia Fontanelli, & Carlo Dani. (2012). Relationship between Platelet Count and Volume and Spontaneous and Pharmacological Closure of Ductus Arteriosus in Preterm Infants. American Journal of Perinatology. 30(5). 359–364. 45 indexed citations
14.
Dani, Carlo, Chiara Poggi, Jacopo Barp, Elettra Berti, & Giulia Fontanelli. (2011). Mean Platelet Volume and Risk of Bronchopulmonary Dysplasia and Intraventricular Hemorrhage in Extremely Preterm Infants. American Journal of Perinatology. 28(7). 551–556. 28 indexed citations
15.
Dani, Carlo, Simone Pratesi, Giulia Fontanelli, Jacopo Barp, & Giovanna Bertini. (2010). Blood transfusions increase cerebral, splanchnic, and renal oxygenation in anemic preterm infants. Transfusion. 50(6). 1220–1226. 111 indexed citations
16.
Dani, Carlo, Iuri Corsini, Giovanna Bertini, et al.. (2010). The INSURE method in preterm infants of less than 30 weeks' gestation. The Journal of Maternal-Fetal & Neonatal Medicine. 23(9). 1024–1029. 54 indexed citations
17.
Fontanelli, Giulia, et al.. (1988). [Acute poisoning with atropine-like alkaloids of Datura Metel].. PubMed. 125(3). 203–11. 1 indexed citations
18.
Terzoli, S, Giulia Fontanelli, & V. Carnelli. (1986). [Treatment of thalassemia].. PubMed. 6(6). 753–4. 1 indexed citations
19.
Fargion, Silvia, V. Gabutti, Antonio Piga, et al.. (1982). Early iron overload in beta-thalassaemia major: when to start chelation therapy?. Archives of Disease in Childhood. 57(12). 929–933. 15 indexed citations
20.
Masera, Giuseppe, S Terzoli, Maria Antonietta Avanzini, et al.. (1982). Evaluation of the supertansfusion regimen in homozygous beta‐thalassaemia children. British Journal of Haematology. 52(1). 111–113. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R Heidler Breakdown of academic impact, for papers by Kres̆imir Gales̃ić Breakdown of academic impact, for papers by V Deutsch Breakdown of academic impact, for papers by Jacob Marsvin Laurberg Breakdown of academic impact, for papers by Y Pawlotsky Breakdown of academic impact, for papers by Raj Warrier Breakdown of academic impact, for papers by Takashi Iwakiri Breakdown of academic impact, for papers by H P Krohn Breakdown of academic impact, for papers by G.B. Fogazzi Breakdown of academic impact, for papers by Andrew Saunders
Rankless by CCL
2026